MedPath

Comparative study of Rasnadi Tail drops nasya and Shadbindu Tail drops nasya in Headache.

Phase 3
Not yet recruiting
Conditions
Headache,
Registration Number
CTRI/2019/12/022564
Lead Sponsor
Sane Gurugi Arogya Kendra
Brief Summary

This study is particularly randomised comaparative clinical trial to evaluate the effect of Rasnadi taila nasya given in nasya  form(liquid )  2 drops in each nostril for 7 days  with Shadbindu taila nasya given same as Rasnadi taila nasya in Vataj Shiroshoola.The primary outcome will be effect of Rasnadi taila nasya in Vataj Shiroshoola and secondary outcome wiil be to decrease the severity of Vataj Shiroshoola.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
72
Inclusion Criteria

1)Patient suffering from symptoms of Vataj Shiroshoola irrespective of time period 2) Patient between age group 20 to 60 years 3)Patient of either gender.

Exclusion Criteria
  • 1)Patients who have known cases of hypertension and dibetes.
  • 2)Secondary headache caused by known cases of meningitis,tumor,encephalitis and refractive errors.
    1. Known cases of pregnancy and lactation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bhrama (giddiness)21 days
Shastra arni nibha (Throbbing pain)21 days
Objective criteria (gradation)21 days
1) Severity of headache21 days
2)frequency of headache21 days
Subjective criteria (by using grades and analouges pain scale)21 days
3)duration of headache21 days
Secondary Outcome Measures
NameTimeMethod
Study the concept of vataj shiroshoola and headache in detailsStudy the Nasya kriya kalpa and its uses,indications,contra indications and the complications.

Trial Locations

Locations (1)

Sane Guruji Arogya Kendra Malwadi, Hadpasar,Pume 411028

🇮🇳

Pune, MAHARASHTRA, India

Sane Guruji Arogya Kendra Malwadi, Hadpasar,Pume 411028
🇮🇳Pune, MAHARASHTRA, India
Dr Vinayak Anaji sirsat
Principal investigator
8668869345
vinusirsat38@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.